ROELSON RODRIGUEZ: Open Payments
NPI 1154919918 · EL PASO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,117 in 115 payments from 15 companies in 2025. Trend: 2023 $1,453 · 2024 $2,042 · 2025 $3,117
Food & beverage: $3,117
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 17 | $943 |
| GlaxoSmithKline, LLC. | 21 | $524 |
| Viatris Specialty LLC | 22 | $394 |
| GENZYME CORPORATION | 12 | $294 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $287 |
| Verona Pharma, Inc. | 15 | $159 |
| Mallinckrodt Hospital Products Inc. | 1 | $117 |
| Insmed, Inc. | 4 | $105 |
| Electromed, Inc. | 8 | $87 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $67 |
Products named: YUPELRI, AIRSUPRA, NUCALA, FASENRA, DUPIXENT, TRELEGY ELLIPTA, OFEV, BREZTRI.
Industry payments across TX — which companies pay providers there.
